Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
11 Oktober 2010 - 3:00PM
Marketwired
Alphatec Holdings, Inc. (NASDAQ: ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures, and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
related to the aging spine, today announced the appointment of
Michael O'Neill, FCMA, as the Company's Chief Financial Officer,
Vice President and Treasurer, effective October 11, 2010. Peter C.
Wulff will transition to the newly created position of Senior Vice
President, Strategic Initiatives, effective immediately.
Mr. O'Neill joins the Company from Mentor Corporation, a
surgical aesthetics manufacturer, where he was Vice President and
Chief Financial Officer from November 2007 to March 2009. Mentor
Corporation was acquired by Johnson & Johnson in January 2009.
Prior to joining Mentor Corporation, Mr. O'Neill had spent the
previous twenty years with Johnson & Johnson, with his
most-recent position being Vice President and Chief Financial
Officer, Johnson & Johnson Worldwide Information Technology.
From 2001 through 2007 Mr. O'Neill served as the Vice President,
Finance and Chief Financial Officer for LifeScan, a division of
Johnson & Johnson, a leading supplier of blood glucose
monitoring systems. Mr. O'Neill began working for Johnson &
Johnson in 1987 and moved through a series of progressively more
responsible positions including International Controller,
Operations Controller, Finance Director, and Group Finance
Director. Mr. O'Neill received a B.A. in Economics and Statistics
from the University of Exeter, Devon, United Kingdom and is a
Fellow of the Chartered Institute of Management Accountants of
Great Britain.
Dirk Kuyper, the Company's President and Chief Executive
Officer, commented, "We are extremely excited to welcome an
experienced professional such as Mike to Alphatec Spine's
management team. Mike's depth of knowledge in the medical device
industry and experience with multi-national operations will allow
him to quickly add value as the Company's CFO."
In his new position, Mr. Wulff will continue to report to the
Company's President and CEO, Dirk Kuyper. Mr. Wulff's
responsibilities will include a number of key initiatives and
projects as well as the continued integration of Scient'x and
Alphatec Spine.
Mr. Kuyper stated, "In the changing environment facing our
industry, we believe that it is necessary to have a member of
senior management that is focused on certain aspects of our
strategic plan, including the Scient'x integration. We believe that
Peter's experience and skill set are a good fit for this new role.
I would like to thank Peter for the leadership role he provided
during his tenure as CFO."
About Alphatec Spine Alphatec Spine, Inc.
is a wholly owned subsidiary of Alphatec Holdings, Inc. (NASDAQ:
ATEC). Alphatec Spine is a medical device company that designs,
develops, manufactures and markets products for the surgical
treatment of spine disorders, primarily focused on the aging spine.
The Company's mission is to combine world-class customer service
with innovative, surgeon-driven design that will help improve the
aging patient's quality of life. The Company is poised to achieve
its goal through new solutions for patients with osteoporosis,
stenosis and other aging spine deformities, improved minimally
invasive products and techniques and integrated biologics
solutions. In addition to its U.S. operations, the Company also
markets its products in over 50 international markets through its
subsidiary, Scient'x S.A., via a direct sales force in France,
Italy and the United Kingdom and via independent distributors in
the rest of Europe, the Middle East and Africa, South America and
Latin America. In Asia and Australia, the Company markets its
products through its subsidiary, Alphatec Pacific, Inc, and through
Scient'x's distributors in China, Korea and Australia.
Also visit the Aging Spine Center, a web-based information
portal for healthcare providers and patients regarding aging spine
disorders and their treatment. Alphatec Spine is working with the
National Osteoporosis Foundation as well as other clinical portals
that provide peer-reviewed content, to populate the Aging Spine
Center. The interactive website will enable patients to review
pertinent information about all the key disorders that affect the
aging spine in an easy-to-understand format that includes videos,
graphics and questions that should be asked of caregivers. Medical
information will include published abstracts regarding the aging
spine.
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Please refer to the risks detailed from time to time in
Alphatec Spine's SEC reports, including quarterly reports on Form
10-Q, reports on Form 8-K and annual reports on Form 10-K. Alphatec
Spine disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, unless required by law.
Alphatec Spine, Inc. Dirk Kuyper President and Chief Executive
Officer (760) 494-6746 Email Contact Westwicke Partners Lynn C.
Pieper (415) 202-5678 Email Contact
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024